Understanding Oceanic Stroke Trial At Isc26
Exploring Oceanic Stroke Trial At Isc26 reveals several interesting facts. Showed Asundexian was associated with a reduced occurrence of ischemic
Key Takeaways about Oceanic Stroke Trial At Isc26
- Mike Sharma, MD, MSc, FRCPC, McMaster University, Hamilton, Canada, discusses two analyses of the
- In the phase 3
- ... shares the primary results from the
- In this video interview, Mike Sharma, MD, MSc, professor of medicine at McMaster University, discussed findings from ...
- ... prespecified secondary analysis of the
Detailed Analysis of Oceanic Stroke Trial At Isc26
Simona Sacco, MD, University of L'Aquila, L'Aquila, Italy, shares her perspective on practice-changing Mike Sharma, MD, MSc, FRCPC, McMaster University, Hamilton, Canada, discusses the ongoing Cheryl Bushnell, MD, MHS, FAHA, Chair,
In this journal club review, we break down the
Stay tuned for more updates related to Oceanic Stroke Trial At Isc26.